Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04763928
Status:
UNKNOWN
Last Update Posted:
2022-01-04
First Post:
2021-02-17
Brief Title:
Trial in AML Secondary to MPNs Patients Unfit for Intensive Chemotherapy Investigating a Treatment Combination Including Decitabine and Venetoclax
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-17
First Submit QC Date:
February 19 2021
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-03
Last Update Post Date:
2022-01-04
Last Update Post Date Type:
ACTUAL